Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma. Bila M, Franken A, Van Dessel J, Garip M, et al. Oral Oncol 2023;149:106664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bila M, Franken A, Van Dessel J, Garip M, et al. Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncol 2023;149:106664.
PMID: 38113661